RAC1 and melanoma: Particularly, the P29S substitution is the most common RAC1 mutation found in malignant melanomas, inducing RAC1 spontaneous activation through the constitutive GDP/GTP nucleotide exchange (Hodis et al., 2012; Davis et al., 2013).